Thermogenesis Holdings, Inc. (THMO): Price and Financial Metrics


Thermogenesis Holdings, Inc. (THMO): $2.47

0.06 (+2.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

THMO POWR Grades


  • Growth is the dimension where THMO ranks best; there it ranks ahead of 72.36% of US stocks.
  • The strongest trend for THMO is in Growth, which has been heading up over the past 31 weeks.
  • THMO ranks lowest in Stability; there it ranks in the 5th percentile.

THMO Stock Summary

  • THMO has a market capitalization of $27,635,339 -- more than approximately only 4.85% of US stocks.
  • Revenue growth over the past 12 months for ThermoGenesis Holdings Inc comes in at -39.32%, a number that bests merely 9.47% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for THMO comes in at -63.1% -- higher than that of just 3.97% of stocks in our set.
  • Stocks that are quantitatively similar to THMO, based on their financial statements, market capitalization, and price volatility, are YAYO, LOV, MAXR, BKYI, and ACB.
  • Visit THMO's SEC page to see the company's official filings. To visit the company's web site, go to www.thermogenesis.com.

THMO Valuation Summary

  • THMO's price/earnings ratio is -2; this is 105.88% lower than that of the median Healthcare stock.
  • Over the past 243 months, THMO's price/sales ratio has gone down 8.1.
  • THMO's EV/EBIT ratio has moved up 8.3 over the prior 243 months.

Below are key valuation metrics over time for THMO.

Stock Date P/S P/B P/E EV/EBIT
THMO 2018-12-14 0.6 0.4 -0.2 -0.1
THMO 2017-02-08 2.2 0.8 -0.8 -0.9
THMO 2011-08-02 1.2 1.5 -20.0 -11.4
THMO 2011-02-01 2.0 2.8 -16.2 -12.9
THMO 2007-10-10 7.9 3.5 -19.5 -18.6
THMO 2007-03-06 11.2 4.1 -30.2 -28.2

THMO Growth Metrics

  • Its 3 year net income to common stockholders growth rate is now at -121.66%.
  • The 5 year price growth rate now stands at -92.91%.
  • The 2 year cash and equivalents growth rate now stands at 73.53%.
THMO's revenue has moved down $1,867,000 over the prior 30 months.

The table below shows THMO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 8.061 -15.804 -14.162
2020-12-31 9.744 -14.393 -16.351
2020-09-30 9.519 -11.601 -17.549
2020-06-30 11.222 -9.302 -17.368
2020-03-31 13.285 -3.358 -12.228
2019-12-31 13.047 -3.26 -9.497

THMO Price Target

For more insight on analysts targets of THMO, see our THMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.00 Average Broker Recommendation 1.5 (Moderate Buy)

THMO Stock Price Chart Interactive Chart >

Price chart for THMO

THMO Price/Volume Stats

Current price $2.47 52-week high $6.45
Prev. close $2.41 52-week low $1.92
Day low $2.32 Volume 532,300
Day high $2.53 Avg. volume 797,660
50-day MA $2.60 Dividend yield N/A
200-day MA $2.60 Market Cap 29.42M

Thermogenesis Holdings, Inc. (THMO) Company Bio


Thermogenesis Holdings, Inc. serves customers in the United States.


THMO Latest News Stream


Event/Time News Detail
Loading, please wait...

THMO Latest Social Stream


Loading social stream, please wait...

View Full THMO Social Stream

Latest THMO News From Around the Web

Below are the latest news stories about ThermoGenesis Holdings Inc that investors may wish to consider to help them evaluate THMO as an investment opportunity.

Loss-Making ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Expected To Breakeven In The Medium-Term

With the business potentially at an important milestone, we thought we'd take a closer look at ThermoGenesis Holdings...

Yahoo | June 8, 2021

ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2021 and Provides Corporate Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2021 and provided a corporate strategic update.

Yahoo | May 13, 2021

ThermoGenesis Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / ThermoGenesis Holdings, Inc. (NASDAQ:THMO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.

Yahoo | May 13, 2021

ThermoGenesis Holdings Announces 2020 Year End Financial Results and Provides Corporate Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2020 and provided a corporate strategic update.

Yahoo | March 17, 2021

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 and provide a corporate strategic update on Wednesday, March 17, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

Yahoo | March 10, 2021

Read More 'THMO' Stories Here

THMO Price Returns

1-mo -6.44%
3-mo 2.49%
6-mo -20.83%
1-year -54.84%
3-year -36.67%
5-year -94.49%
YTD 18.18%
2020 -52.50%
2019 64.79%
2018 -91.10%
2017 -13.04%
2016 -4.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9288 seconds.